Therapeutics

Eric Adam Joins HAYA Therapeutics as Chief Operating Officer

July 25, 2024

GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics

July 24, 2024

Rondo Therapeutics Appoints Steven James to Board of Directors

July 11, 2024

Beacon Therapeutics Secures $170 Million in Series B Funding

July 9, 2024

Carisma Therapeutics Appoints Marella Thorell and David Scadden to Board of Directors

July 9, 2024

Curie.Bio Closes $380M Fund to Boost Early-Stage Therapeutics

July 1, 2024

TwoStep Therapeutics Launches with $6.5M Seed Funding to Tackle Solid Tumors

June 28, 2024

MOMA Therapeutics Welcomes New Leadership Team Members

June 28, 2024

Seaport Therapeutics Expands Executive Team with Key Appointments

June 20, 2024

Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment

June 20, 2024